CD8A and neoplasm: With a next‐generation vaccine adjuvant, it is demonstrated that position‐scanning peptide libraries of tumor antigens themselves can serve as improved immunogens to induce Ag‐specific CD8+ T cells with greater frequency and function compared to the wild‐type epitope.